Sfoglia per Rivista  LIVER INTERNATIONAL

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 16 a 35 di 57
Titolo Data di pubblicazione Autore(i) File
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 1-gen-2019 Sorbo, Maria C; Carioti, Luca; Bellocchi, Maria C; Antonucci, Francescopaolo; Sforza, Daniele; Lenci, Ilaria; Ciancio Manuelli, Matteo; Armenia, Daniele; De Leonardis, Francesco; Milana, Martina; Manzia, Tommaso M; Angelico, Mario; Tisone, Giuseppe; Cento, Valeria; Perno, Carlo F; Ceccherini-Silberstein, Francesca
HCV screening: Moving from theory to practice 1-gen-2020 Parigi, Tommaso Lorenzo; Aghemo, Alessio
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 1-gen-2017 Lleo, A; Bruno, S; Colombo, M
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? 1-gen-2017 Orsi, E; Grancini, V; Menini, S; Aghemo, A; Pugliese, G
High prevalence of multidrug-resistant bacteria in patients with pyogenic liver abscess following liver cancer loco-regional treatments 1-gen-2021 Colapietro, Francesca; Masetti, Chiara; Ceriani, Roberto; Morelli, Paola; Poretti, Dario; Pedicini, Vittorio; Pugliese, Nicola; Voza, Antonio; Lleo, Ana; Aghemo, Alessio
High prevalence of porto-sinusoidal vascular disease in patients with constantly elevated gamma-glutamyl transferase levels 1-gen-2022 Pugliese, N; di Tommaso, L; Lleo, A; Alfarone, L; Mastrorocco, E; Terrin, M; Ceriani, R; Colapietro, F; Terracciano, L; Aghemo, A
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study 1-gen-2020 Mancuso, Me; Linari, S; Santagostino, E; Bartolozzi, D; D'Ambrosio, R; Borghi, M; Lampertico, P; Peyvandi, F; Castaman, G; Aghemo, A
How to optimize HCV therapy in genotype 2 patients 1-gen-2013 Grassi, E; Aghemo, A
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry? 1-gen-2023 Vogel, Arndt; Lleo, Ana
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma 1-gen-2022 Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response 1-gen-2017 Bruno, S; Di Marco, V; Iavarone, M; Roffi, L; Boccaccio, V; Crosignani, A; Cabibbo, G; Rossi, S; Calvaruso, V; Aghemo, A; Giacomelli, L; Craxi, A; Colombo, M; Maisonneuve, P
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis 1-gen-2020 Díaz-González, Á; Sanduzzi-Zamparelli, M; Gomes da Fonseca, Ll; Di Costanzo, Gg; Alves, R; Iavarone, M; Leal, C; Sacco, R; Matilla, Am; Hernández-Guerra, M; Aballay Soteras, G; Wörns, Ma; Pinter, M; Varela, M; Ladekarl, M; Chagas, Al; Mínguez, B; Arenas, Ji; Granito, A; Sánchez-Torrijos, Y; Rojas, Á; Rodríguez de Lope, C; Alvares-da-Silva, Mr; Pascual, S; Rimassa, L; Lledó, Jl; Huertas, C; Sangro, B; Giannini, Eg; Delgado, M; Vergara, M; Perelló, C; Lue, A; Sala, M; Gallego, A; Coll, S; Hernáez, T; Piñero, F; Pereira, G; França, A; Marín, J; Anders, M; Mello, V; Lozano, M; Nault, Jc; Menéndez, J; García Juárez, I; Bruix, J; Reig, M
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? 1-gen-2022 Terziroli Beretta-Piccoli, Benedetta; Lleo, Ana
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 1-gen-2015 Giannone, Ferdinando; Domenicali, Marco; Baldassarre, Maurizio; Bartoletti, Michele; Naldi, Marina; Laggetta, Maristella; Bertucci, Carlo; Clecchia, A; Viale, Pierluigi; Bernardi, Mauro; Caraceni, Paolo
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis 1-gen-2021 Casadei-Gardini, Andrea; Scartozzi, Mario; Tada, Toshifumi; Yoo, Changhoon; Shimose, Shigeo; Masi, Gianluca; Lonardi, Sara; Frassineti, Luca Giovanni; Nicola, Silvestris; Piscaglia, Fabio; Kumada, Takashi; Kim, Hyung-Don; Koga, Hironori; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Bang, Yeonghak; Atsukawa, Masanori; Torimura, Takuji; Tsuj, Kunihiko; Itobayashi, Ei; Toyoda, Hidenori; Fukunishi, Shinya; Rimassa, Lorenza; Rimini, Margherita; Cascinu, Stefano; Cucchetti, Alessandro; Arai, Taeang
Liver International: Anticipating the future of hepatology worldwide 1-gen-2019 Valenti, L; Aghemo, A; Forner, A
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey 1-gen-2021 Ponziani, Francesca Romana; Aghemo, Alessio; Cabibbo, Giuseppe; Masarone, Mario; Montagnese, Sara; Petta, Salvatore; Russo, Francesco Paolo; Lai, Quirino
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma 1-gen-2012 Augello, C.; Vaira, V.; Caruso, L.; Destro, A.; Maggioni, M.; Park, Y. N.; Montorsi, M.; Santambrogio, R.; Roncalli, M.; Bosari, S.
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma 1-gen-2015 Vaira, V; Roncalli, M; Carnaghi, C; Faversani, A; Maggioni, M; Augello, C; Rimassa, L; Pressiani, T; Spagnuolo, G; Di Tommaso, L; Fagiuoli, S; Caremoli, Er; Barberis, M; Labianca, R; Santoro, A; Bosari, S
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 1-gen-2017 Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Rossi, P; Barbaliscia, S; Melis, M; Verucchi, G; Magni, Cf; Teti, E; Bertoli, A; Antonucci, F; Bellocchi, Mc; Micheli, V; Masetti, C; Landonio, S; Francioso, S; Santopaolo, F; Pellicelli, Am; Calvaruso, V; Gianserra, L; Siciliano, M; Romagnoli, D; Cozzolongo, R; Grieco, A; Vecchiet, J; Morisco, F; Merli, M; Brancaccio, G; Di Biagio, A; Loggi, E; Mastroianni, Cm; Pace Palitti, V; Tarquini, P; Puoti, M; Taliani, G; Sarmati, L; Picciotto, A; Vullo, V; Caporaso, N; Paoloni, M; Pasquazzi, C; Rizzardini, G; Parruti, G; Craxì, A; Babudieri, S; Andreoni, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F; Mariani, R; Iapadre, N; Grimaldi, A; Cozzolongo, R; Andreone, P; Verucchi, G; Menzaghi, B; Quirino, T; Pisani, V; Torti, C; Vecchiet, J; Bruzzone, B; De Maria, A; Marenco, S; Nicolini, La; Viscoli, C; Casinelli, K; Delle Monache, M; Lichtner, M; Aghemo, A; Boccaccio, V; Bruno, S; Cerrone, M; Colombo, M; D'Arminio Monforte, A; Danieli, E; Donato, F; Gubertini, G; Lleo, A; Magni, Cf; Mancon, A; Monico, S; Niero, F; Russo, Ml; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Brancaccio, G; Gaeta, Gb; Lembo, V; Sangiovanni, V; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Pieri, A; Polilli, E; Sozio, F; Antenucci, F; Aragri, M; Baiocchi, L; Barbaliscia, S; Biliotti, E; Biolato, M; Carioti, L; Ceccherini-Silberstein, F; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, Vc; Di Paolo, D; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Lula, R; Malagnino, V; Manuelli, M; Miglioresi, L; Milana, M; Moretti, A; Nosotti, L; Palazzo, D; Pellicelli, A; Romano, M; Sarrecchia, C; Sforza, D; Sorbo, Mc; Spaziante, M; Svicher, V; Tisone, G; Vespasiani-Gentilucci, U; D'Adamo, G; Mangia, A; Maida, I; Mura, Ms; Falconi, L; Di Giammartino, D.
Mostrati risultati da 16 a 35 di 57
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile